GO-17A3 Bispecific antibody (GO Therapeutics)

N/A

Report date: 2025/03/25 14:45:46

Base Information

Drug NameGO-17A3 Bispecific antibody (GO Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMelanomaSarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGo Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesGo Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMelanomaSarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A